Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy. Aromatase inhibitor, Bisphosphonate, Breast cancer, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), Zoledronate
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study Bisphosphonate, Hologic, Longitudinal, Osteoporosis, Switzerland, Treatment (anti-osteoporotic treatments), Zoledronate